FSLBX
Price
$167.23
Change
-$0.43 (-0.26%)
Updated
Jun 22 closing price
Net Assets
941.07M
HSSCX
Price
$25.32
Change
-$0.04 (-0.16%)
Updated
Jun 22 closing price
Net Assets
44.4M
Interact to see
Advertisement

FSLBX vs HSSCX

FSLBX vs HSSCX Comparison Chart in %
View a ticker or compare two or three
VS
FSLBX vs. HSSCX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLBX is a Hold and HSSCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSLBX has more cash in the bank: 941M vs. HSSCX (44.4M). FSLBX pays higher dividends than HSSCX: FSLBX (0.72) vs HSSCX (0.00). FSLBX was incepted earlier than HSSCX: FSLBX (41 years) vs HSSCX (26 years). HSSCX (2.44) is less costly to investors than FSLBX (0.66). HSSCX is a more actively managed with annual turnover of: 32.00 vs. FSLBX (10.00). FSLBX has a lower initial minimum investment than HSSCX: FSLBX (0) vs HSSCX (2000). HSSCX annual gain was more profitable for investors over the last year : 13.16 vs. FSLBX (-7.77). FSLBX return over 5 years is better than : 51.40 vs. HSSCX (-30.54).
FSLBXHSSCXFSLBX / HSSCX
Total Expense Ratio0.662.4427%
Annual Report Gross Expense Ratio0.662.4427%
Fund Existence41 years26 years-
Gain YTD-12.1740.396-3,075%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets941M44.4M2,119%
Annual Yield % from dividends0.720.00-
Returns for 1 year-7.7713.16-59%
Returns for 3 years58.9668.9685%
Returns for 5 years51.40-30.54-168%
Returns for 10 years227.637.842,904%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICEUX54.570.06
+0.11%
NYLI Epoch International Choice Class I
JEMSX56.18N/A
N/A
JPMorgan Emerging Markets Equity I
NMMGX11.10N/A
N/A
Northern Multi-Manager Glbl Real Estate
LOGWX46.71N/A
N/A
Lord Abbett Developing Growth F3
PXSCX21.27-0.03
-0.14%
Impax Small Cap Investor